San Diego startup 9am.health has raised $16 million in a first round of venture capital to expand its subscription service to help people manage Type 2 diabetes and prediabetes.
Founded in 2021, the company provides digital access to a care team, at home monitoring kits, mail-in lab diagnostics, personalized treatment plans and prescription medications ordered online and delivered to the home.
“People want a new approach that fits with their busy lives, so 9am.health gives them a relationship-driven model that doesn’t sacrifice quality for lower cost,” said Frank Westermann, co-founder and co-chief executive of the company .
Prediabetes and Type 2 are among the most prevalent chronic conditions in the US About 96 million Americans over 18 suffer from prediabetes, according to estimates by the Centers for Disease Control.
Both conditions typically don’t require insulin. They’re managed through medication, diet and exercise.
Founded by Westermann, Anton Kittelberger, Paul Geevarghese and Bernhard Schandl, 9am.health’s subscription service is now available in 47 states and Washington, DC
Westermann and Kittelberger live with diabetes. The base subscription costs $25 per month for access to virtual care and online medication orders/delivery. There are also add-ons, such as lab tests for an additional $15 a month.
A subscription to 9am.health is not covered by insurance, although the company is working on making it available as a benefit through employer self-insurance programs.
As part of the funding, 7Wire Venture Managing Partner Glen Tullman will join 9am.health’s board of directors.
“The 9am.health team has created a new consumer-directed and comprehensive diabetes experience that includes medications, devices, labs, and care, provided by people who understand diabetes, all in one place,” said Tullman. “The pandemic demonstrated that health consumers are hungry for a new healthcare system that is responsive to their needs, improves care and does so affordably.”